ARTICLE | Clinical News
Technosphere Insulin System: Phase II data
April 24, 2006 7:00 AM UTC
In an open-label, European Phase II trial in 110 patients, mean post-meal rises in glucose were 18.7 mg/dl in patients given Technosphere inhaled insulin compared to 46.8 mg/dl for those given NovoLo...